Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085709
Status:
COMPLETED
Last Update Posted:
2015-09-30
First Post:
2004-06-14
Brief Title:
S0106 Cytarabine and Daunorubicin w or wo Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
Sponsor:
Organization:
SWOG Cancer Research Network